VLCC Health Care Ltd., founded by Mrs. Vandana Luthra in 1989, has evolved into one of India\u2019s leading players in the wellness and beauty industry. Known for its wellness clinics, personal care products, and institutes for skill development in beauty and nutrition, VLCC has established a strong brand presence over the years. Now, the company is set to launch its Initial Public Offering (IPO) to raise funds for future growth.<\/p>\n\n\n
VLCC started as a single beauty and weight management center in New Delhi and has grown into a prominent brand with over 330 locations across 150+ cities in India and 12 countries, including South Asia, Southeast Asia, and the Gulf Cooperation Council (GCC) region. The company\u2019s offerings include wellness programs, weight management solutions, personal care products, nutraceuticals, and skill development training through its branded VLCC Institutes.<\/p>\n\n\n\n
The company operates through three core business segments:<\/p>\n\n\n\n
The VLCC IPO aims to raise \u20b9300 crores through fresh issue shares, which will be used for various purposes, including brand development, expanding wellness clinics, and investing in digital infrastructure. The issue includes both fresh shares and an offer for sale by existing shareholders.<\/p>\n\n\n\n
Here are the key details of the IPO:<\/p>\n\n\n\n The company plans to use the net proceeds from the IPO for several key objectives:<\/p>\n\n\n\n Here\u2019s a look at VLCC Health Care\u2019s latest financials:<\/p>\n\n\n\n Despite the challenges posed by the pandemic in FY2020, VLCC has bounced back with improved profitability, as reflected in the significant reduction in losses and the positive PAT in FY2021. The company’s EBITDA margin has also improved over the years, showing better operational efficiency.<\/p>\n\n\n\n VLCC Health Care\u2019s IPO presents an interesting investment opportunity, especially for those looking to invest in the growing wellness and beauty sector in India. The company\u2019s strong brand presence, diversified offerings, and growth prospects make it an appealing choice for long-term investors. However, investors should consider the risks, particularly the impact of economic disruptions and competition, before making an investment decision.<\/p>\n\n\n\n If VLCC\u2019s IPO is priced attractively compared to its peers, it could be a solid addition to an investor\u2019s portfolio, given the sector\u2019s positive growth outlook in the coming years.<\/p>\n\n\n\n Source:<\/strong><\/p>\n\n\n\nDetails<\/strong><\/td> Information<\/strong><\/td><\/tr> Total Issue Size<\/strong><\/td> \u20b9300 crore<\/td><\/tr> Issue Type<\/strong><\/td> Book Built<\/td><\/tr> Stock Exchange<\/strong><\/td> NSE, BSE<\/td><\/tr> Fresh Issue<\/strong><\/td> \u20b9300 crore<\/td><\/tr> QIB Portion<\/strong><\/td> 75%<\/td><\/tr> NIB Portion<\/strong><\/td> 15%<\/td><\/tr> Retail Portion<\/strong><\/td> 10%<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n VLCC Health Care IPO Objectives<\/strong><\/h3>\n\n\n\n
\n
Why Should You Invest in VLCC Health Care IPO?<\/strong><\/h3>\n\n\n\n
\n
Financial Performance<\/strong><\/h3>\n\n\n\n
Particulars (\u20b9 Crores)<\/strong><\/td> FY2021<\/strong><\/td> FY2020<\/strong><\/td> FY2019<\/strong><\/td><\/tr> Revenue from Operations<\/strong><\/td> 532.92<\/td> 769.57<\/td> 852.43<\/td><\/tr> EBITDA<\/strong><\/td> 150.12<\/td> 147.89<\/td> 123.30<\/td><\/tr> EBITDA Margin (%)<\/strong><\/td> 26.6%<\/td> 19.1%<\/td> 14.3%<\/td><\/tr> Profit After Tax (PAT)<\/strong><\/td> 6.24<\/td> -15.41<\/td> -48.68<\/td><\/tr> EPS (\u20b9)<\/strong><\/td> 1.62<\/td> -4.09<\/td> -12.93<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n Strengths of VLCC Health Care<\/strong><\/h3>\n\n\n\n
\n
Risks of Investing in VLCC Health Care IPO<\/strong><\/h3>\n\n\n\n
\n
Conclusion: Should You Invest?<\/strong><\/h3>\n\n\n\n